Cite
HARVARD Citation
Front, S. et al. (2018). 4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations. Bioorganic & medicinal chemistry. 26 (20), pp. 5462-5469. [Online].